Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Esophagus
Published in: Esophagus 1/2010

01-03-2010 | Original Article

Late toxicity after definitive chemoradiotherapy for esophageal squamous cell carcinoma

Authors: Kazuhiro Nishikawa, Kazuhiro Iwase, Toyokazu Aono, Masaya Nomura, Hiroshi Tamagawa, Chu Matsuda, Tsuyoshi Takahashi, Shigetoshi Shimamoto, Shunji Endo, Yasuhiro Tanaka

Published in: Esophagus | Issue 1/2010

Login to get access
Metadata
Title
Late toxicity after definitive chemoradiotherapy for esophageal squamous cell carcinoma
Authors
Kazuhiro Nishikawa
Kazuhiro Iwase
Toyokazu Aono
Masaya Nomura
Hiroshi Tamagawa
Chu Matsuda
Tsuyoshi Takahashi
Shigetoshi Shimamoto
Shunji Endo
Yasuhiro Tanaka
Publication date
01-03-2010
Publisher
Springer Japan
Published in
Esophagus / Issue 1/2010
Print ISSN: 1612-9059
Electronic ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-010-0224-x

Other articles of this Issue 1/2010

Esophagus 1/2010 Go to the issue

Case Report

A case of metastatic esophageal tumor from breast cancer

Case Report

Surgical management of hiatus hernia with chronic gastric volvulus: report of two cases

Special Article

Comprehensive Registry of Esophageal Cancer in Japan, 2002

How I Do It

Traction suture technique of the pericardium to suspend the heart for excellent exposure in abdominal-transhiatal approach

Congress Report: Invited Lecture

Multimodality treatment of esophagus cancer: current status and future perspectives in the United States

Case Atlas

Induction chemotherapy followed by definitive chemoradiation: a new nonsurgical strategy for treating esophageal cancer?
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits